Cargando…

Management of patients with autoimmune liver disease during COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Lleo, Ana, Invernizzi, Pietro, Lohse, Ansgar W., Aghemo, Alessio, Carbone, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151539/ https://www.ncbi.nlm.nih.gov/pubmed/32283134 http://dx.doi.org/10.1016/j.jhep.2020.04.002

Ejemplares similares

Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges
por: Pugliese, Nicola, et al.
Publicado: (2022)

Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases
por: Zhang, Haiyan, et al.
Publicado: (2015)

Tolerance and autoimmunity in the liver
por: Schramm, Christoph, et al.
Publicado: (2022)

Role of liver biopsy in hepatocellular carcinoma
por: Di Tommaso, Luca, et al.
Publicado: (2019)

Artificial intelligence for precision medicine in autoimmune liver disease
por: Gerussi, Alessio, et al.
Publicado: (2022)

The risk of liver cancer in autoimmune liver diseases
por: Lleo, Ana, et al.
Publicado: (2019)

“Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis
por: Sebode, Marcial, et al.
Publicado: (2017)

Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver
por: Aghemo, Alessio, et al.
Publicado: (2020)

New Therapeutic Targets in Autoimmune Cholangiopathies
por: Gerussi, Alessio, et al.
Publicado: (2020)

Management of autoimmune disease during the COVID-19 pandemic
por: Robinson, Philip C, et al.
Publicado: (2020)

Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey
por: Zecher, Britta Franziska, et al.
Publicado: (2021)

Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature
por: Invernizzi, Pietro, et al.
Publicado: (2012)

Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury
por: Lleo, Ana, et al.
Publicado: (2022)

Liver tests abnormalities in COVID-19: trick or treat?
por: Vespa, Edoardo, et al.
Publicado: (2020)

Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients
por: Gerussi, Alessio, et al.
Publicado: (2020)

Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report
por: Covini, Giovanni, et al.
Publicado: (2018)

Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment
por: Garetto, Stefano, et al.
Publicado: (2015)

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
por: Papamichalis, Panagiotis A, et al.
Publicado: (2007)

Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care
por: Rüther, Darius Ferenc, et al.
Publicado: (2022)

An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study
por: Laino, Maria Elena, et al.
Publicado: (2022)

B cells in autoimmune hepatitis: bystanders or central players?
por: Schultheiß, Christoph, et al.
Publicado: (2022)

Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
por: Steinmann, Silja, et al.
Publicado: (2023)

Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
por: Binatti, Eleonora, et al.
Publicado: (2022)

The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics
por: Bianchi, Ilaria, et al.
Publicado: (2012)

Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations
por: Vespa, Edoardo, et al.
Publicado: (2021)

COVID-19 Vaccine Acceptance among Liver Transplant Recipients
por: Costantino, Andrea, et al.
Publicado: (2021)

Biologics in systemic autoimmune diseases during COVID-19 pandemic
por: Annapureddy, Narender, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on management of autoimmune and inflammatory diseases in Morocco
por: Wafa, Ammouri, et al.
Publicado: (2020)

COVID-19 and Autoimmune Liver Diseases
por: Floreani, Annarosa, et al.
Publicado: (2022)

Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE‐LIVER online survey
por: Wunsch, Ewa, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
por: Duengelhoef, Paul, et al.
Publicado: (2022)

Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic
por: Engelmann, Petra, et al.
Publicado: (2022)

Successful urgent liver transplant due to fulminant autoimmune hepatitis during the height of the COVID-19 pandemic in Spain()
por: Rodríguez-Gandía, Miguel A., et al.
Publicado: (2020)

Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered
por: Plaz Torres, Maria Corina, et al.
Publicado: (2019)

A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis
por: Manno, Valerio, et al.
Publicado: (2019)

COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy
por: Aghemo, Alessio, et al.
Publicado: (2020)

Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis
por: Schultheiß, Christoph, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0kguobakg4bj6uigqkt6iqu8c2